Key facts
- It has raised $7.0M; the latest was PE Growth/Expansion in Jan 2026.
- Notable investors include Lunchline Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for CureCare
- ·The full record, as it builds
Funding rounds
No funding rounds for CureCare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CureCare
Provider of infusion nursing services intended based in Canton, Connecticut. The company offers clinical trial nursing and in-home health care services and treatments for patients suffering from acute and chronic illnesses, enabling patients with acute or chronic conditions and partnering pharmacies to receive timely care in their preferred location.
- Sector
- Healthcare
- HQ
- Canton, CT, United States
- Founded
- 2011
- Website
- curecare.com/
- Ownership
- Privately Held (backing)
CureCare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CureCare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CureCare in its N-PORT filings yet. We sweep new filings monthly.